Abbott LaboratoriesvsOrganon & Co.

ABT and OGN stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$103.87

Value $180B

-0.58%
ABT's page

Abbott Laboratories (ABT) has a market value of $180B and Organon & Co. (OGN) $3.6B. Over the last year, with dividends, ABT moved -18.1% and OGN +82.2%. The P/E is 38.4 for ABT and 17.0 for OGN. Dividend yield: ABT 2.43%, OGN 0.58%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$180B

    OGN$3.6B

    ABT is 50 times OGN

  • Revenue, 12 months

    ABT$48.2B

    OGN$6.1B

    ABT is 7.9 times OGN

  • Net income, 12 months

    ABT$4.7B

    OGN$213M

    ABT is 22 times OGN

  • Operating margin

    ABT13.8%

    OGN–

  • ROIC

    ABT6.3%

    OGN4.2%

    2.1 points apart

  • P/E

    ABT38.4

    OGN17.0

    ABT is 2.3 times OGN

  • Dividend yield

    ABT2.4%

    OGN0.6%

    1.8 points apart

  • 5-year return

    ABT-10.1%

    OGN-46.3%

    36.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-10.1%

OGN-46.3%

5010020222023202420252026
Returns by period
PeriodABTWith dividendsOGNWith dividends
1 year since November 18, 2025-18.1%Price -20.1%+82.2%Price +80.4%
3 years since November 17, 2023+11.1%+3.6% a yearPrice +4.3%+34.9%+10.5% a yearPrice +23.0%
5 years since November 18, 2021-10.1%-2.1% a yearPrice -18.6%-46.3%-11.7% a yearPrice -56.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesOGNOrganon & Co.

Valuation

ABTOGN
Valuation
Price$103.87$13.91
Market value$180B$3.6B
Enterprise value (EV)$207B$10.7B
P/E38.417.0
P/E, 5-year median33.75.7
P/B3.53.0
EV/EBIT31.221.3
Free cash flow yield3.7%18.6%

Results and growth

ABTOGN
Results and growth
Revenue, 12 months$48.2B$6.1B
Net income, 12 months$4.7B$213M
Free cash flow, 12 months$6.8B$675M
Earnings per share, 12 months$2.69$0.77
Revenue growth, year on year5.7%-2.9%
Revenue growth a year, past+5.1%over 5 years-1.0%over 5 years
EPS growth a year, past+8.3%over 5 years-39.0%over 5 years

Margins and returns on capital

ABTOGN
Margins and returns on capital
Gross margin56.9%53.1%
Operating margin13.8%–
Net margin9.8%3.5%
ROIC6.3%4.2%
ROE9.1%22.4%

Balance sheet

ABTOGN
Balance sheet
Cash$4.3B$1.5B
Total debt$31.2B$8.6B
Net debt / EBITDA3.310.8
Interest cover6.7×1.1×

Dividends and buybacks

ABTOGN
Dividends and buybacks
Dividend yield2.4%0.6%
Dividend per share, 12 months$2.52$0.08
Dividend growth a year, past+10.4%over 5 years–
Buyback yield0.5%–
Shareholder yield2.9%0.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or OGN

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or Organon & Co.?

By market value, Abbott Laboratories ($180B) is about 49.8 times Organon & Co. ($3.6B), at today's prices.

How did ABT and OGN stock do over the last 5 years?

Since November 18, 2021, ABT's price moved -18.6% and OGN's -56.0%. With dividends: ABT -10.1% (-2.1% a year), OGN -46.3% (-11.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or OGN?

The dividend yield at today's price is 2.43% for Abbott Laboratories and 0.58% for Organon & Co.. Over the last twelve months they paid $2.52 and $0.08 per share.

What is the P/E of ABT and OGN?

At today's price, the P/E is 38.4 for ABT and 17.0 for OGN. The median of the last five years was 33.7 and 5.7, which shows where each stands against its own past.

Which has the higher profit margins, Abbott Laboratories or Organon & Co.?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 3.5% for Organon & Co., and the operating margin 13.8% and –. Revenue was $48.2B and $6.1B.

Which is the better investment, Abbott Laboratories or Organon & Co.?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.